Guest guest Posted January 21, 2005 Report Share Posted January 21, 2005 Trial of cognitive behavioral therapy in CFS sparks criticism Rheumawire Jan 20, 2005 Zosia Chustecka Nijmegen, the Netherlands - A clinical trial in adolescents with chronic fatigue syndrome (CFS) that concludes cognitive behavioral therapy (CBT) is an " effective treatment " has been harshly criticized. Several researchers are questioning what " effective " means, considering many of the participants continue to have symptoms and are unable to attend school. The trial has also sparked a debate about the ideology behind the CBT approach to this condition, which is based on the underlying belief that CFS is a psychosomatic illness, say critics. The trial was carried out by Dr Maja Stulemeijer (Expert Centre for Chronic Fatigue, Nijmegen University, the Netherlands) and colleagues, reported online December 7, 2004 in BMJ and published in the January 1, 2005 issue [1]. The criticisms appear as email rapid responses. Stulemeijer et al explain that CBT has already been shown to be effective in adults with chronic fatigue syndrome in several randomized controlled trials, but this is the first controlled study to be carried out in adolescents. The participants in the trial were aged between 10 and 17.2 years (to allow completion of the study before they reached 18). " Development of potentially effective interventions is especially important in young people to avoid prolonged absence from school and restricted social activities, which threaten healthy development, " the researchers comment. Sixty-nine adolescents were randomized either to receive CBT (carried out in 10 individual sessions over 5 months) or to a waiting list. In addition, the adolescents were divided into 2 groups depending on their level of activity. The majority were considered to be " active patients " (70% of those assigned to CBT and 79% of those on the waiting list). They were relatively active and alternated between periods of activity and periods of rest, and they were taught to recognize and accept their current state of fatigue and impairment, the researchers explain. " Subsequently, they reduced their levels of activity and learned to respect the limitations. After achieving this balance, the patient started to build up activity levels. " The other group of " passive patients " (30% of CBT and 21% on a waiting list) spent most of their time lying down and went out infrequently. Most did not attend school. " We started a systematic program of building activity as soon as possible, " the researchers comment, after " challenging their beliefs that activity would aggravate symptoms. " Stulemeijer and colleagues report that CBT was more effective than remaining on a waiting list in reducing the severity of fatigue, improving physical functioning, and increasing school attendance. Almost 60% of those in the CBT group returned to full time education, an important indication of recovery, they comment. Treatment resulted in a greater proportion of patients with clinically significant change in these variables, more self-reported improvement, and a significant reduction in several additional symptoms. However, many of the young people continued to report additional symptoms, but the researchers comment that " a complete resolution of additional symptoms is not a requirement of recovery, as has been suggested before. " Passive and active patients showed equal improvement on all primary outcome variables. Stulemeijer et al conclude that CBT is an effective treatment for chronic fatigue syndrome in adolescents and add that these results endorse the findings of previous studies on the efficacy of CBT for adults with this condition. But several correspondents take issue with this conclusion. " In my day, 'effective' meant more than 'useful to a degree,' " writes Ellen Goudsmit, a psychologist trained in behavioral therapy based in Teddington, UK. She points out that at the end of the trial, over 42% of adolescents were still unable to go to school full-time and the mean physical functioning score remained below normal. In addition, about 30% of the participants did not rate themselves as improved. And only some symptoms were alleviatedfatigue, sleep, and muscle pain improved, but there was little change in others such as impaired concentration and memory, tiredness after exercise, headache, sore throat, and sensitive lymph nodes. Abhijit Chaudhuri, senior lecturer in clinical neurosciences at the University of Glasgow, Scotland, criticizes several aspects of the study. There was a high dropout rate (nearly 20% in the intervention arm), and the control group on the waiting list could have been offered contact with health professionals but not CBT, as it may have been this regular contact itself that was beneficial. " This study does not have the strength to conclude that CBT is an effective treatment for chronic fatigue in adolescents, " Chaudhuri says, and he expects an amendment regarding this conclusion from the authors and/or editors. " Failure to do so would perpetuate the view that the BMJ has a selective bias toward research that supports a psychological view of chronic fatigue syndrome irrespective of the quality of the presented material. " The researchers " construct a meaning of 'recovery' as still having symptoms, " and this is " ludicrous, " says Kennedy, a lecturer in social science (Essex, UK). Assigning the discursive categories of " active " and " passive " suggests that functional impairment is somehow " optional, " which is " a clear betrayal of the researchers' ideological assumptions, " she says. The authors quite obviouslyfrom their narrative subscribe to the belief that CFS is a psychosomatic illness and assume that young people with CFS have perpetuating health beliefs about their illness that need to be challenged, she adds. And the list of references contains an abundance of papers produced by proponents of the psychiatric paradigm of CFS. Kennedy says the authors " therefore hold a specific ideological standpoint which is contested, but which means they also hold certain assumptions that bias their research approach. They believe that their patients have a psychosomatic illness that can be 'cured' or that 'recovery' from such illness can be effected by challenging their patients' 'illness beliefs.' This approach cannot be proven as a definitive success and has been shown to be potentially harmful. " Goudsmit comments that " yet another " study on CBT isn't needed, especially if there are no immunological and neurological measures. " We already have a considerable amount of information on the effectiveness of CBT and what we need now is more biomedical research, " she says. " We need to focus our attention on developing a diagnostic test and evaluating new antiviral drugs. " Stulemeijer and the lead author, Gils Bleijenberge (professor of psychology, Expert Centre for Chronic Fatigue, Nijmegen University), when approached by rheumawire about these criticisms, commented: " Studies on CBT for CFS have always led to a lively debate, and our study indeed is no exception. " They responded to the criticisms as follows: " First of all, we believe that our study clearly shows that many of the participants benefited from CBT. Many of the participants of our study were able to function as normal adolescents at the end of treatment, whereas many youngsters on the waiting list still experienced substantial limitations in daily functioning. To name a few results, after 10 sessions of CBT, 71% of the youngsters reported to be completely recovered or to feel much better, and 60% attend school full time. Furthermore, unpublished follow-up shows that the results are maintained at least 3 months after the end of therapy even in the absence of contacts with the therapist. Because CBT has led to large improvements in a substantial portion of all patients in our study, we conclude that CBT can be effectively applied to treat adolescents with CFS. We agree that CBT is not a cure for all CFS patients. As in other chronic conditions, no 1 therapy leads to recovery in all patients or establishes the same effect for all patients. " " Second, we would like to stress that the assumption of several respondents that we consider CFS to be a psychological condition because we treat patients with a primarily psychological approach is incorrect. The views expressed enforce the old paradigm in which diseases or complaints were considered as somatic or psychogenic in origin. We do not deny that physical factors, such as a virus, may have caused the CFS symptomatology, but we do believe that once the illness has started, its expression is affected by beliefs, coping styles, and behaviors; also, physiological and other psychological processes may act in some way or the other to maintain and/or modify the disease process. This view is based on extensive empirical evidence yielded by our own research group as well as by others. Our research group has always applied such a biopsychosocial approach to study CFS and applies many different techniques to explore mechanisms in CFS symptoms. Therefore we are also busy trying to detect the neurobiological mechanisms in CFSfor example, by investigations with functional and structural magnetic resonance imaging, with clinical neurophysiological investigations, and with research into the serotonergic system. " However, they emphasize that " CBT is aimed at influencing factors that are repeatedly found to be involved in the perpetuation of symptoms in CFS " and point out that " at present, there are no evidence-based treatments available for adolescents with CFS, and our study is the first systematic and controlled evaluation of CBT for CFS in adolescents. " Stulemeijer and Blenijenberg tell rheumawire, " We hope that scientists from different fields and with different methods continue to put effort in finding ways to help youngsters with CFS overcome this debilitating condition and enable them to live their lives like healthy teens. Because in the end, isn't that what it's all about? " Source Stulemeijer M, de Jong LWAM, Fiselier TJW, et al. Cognitive behavioural therapy for adolescents with chronic fatigue syndrome: randomised controlled trial. BMJ 2005; 330:14. I'll tell you where to go! Mayo Clinic in Rochester http://www.mayoclinic.org/rochester s Hopkins Medicine http://www.hopkinsmedicine.org Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.